A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Antoni Ribas, MD
UCLA School of Medicine (Melanoma)
Principal Investigator - Ezra Cohen, MD
UCSD Moores Cancer Center (HNSCC)
Principal Investigator - Thomas Tüting, MD
University Hospital Magdeburg
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Tweed Hospital
Tweed Heads, New South Wales, Australia
- Liverpool Hospital
Westmead, New South Wales, Australia
- Melanoma Institute
Wollstonecraft, New South Wales, Australia
- Adelaide Cancer Centre - Ashford Cancer Centre
Kurralta Park, South Australia, Australia
- Hollywood Private Hospital / Affinity Research
Nedlands, Western Australia, Australia
- Charité - Universitätsmedizin Berlin
Berlin, Germany
- Klinikum Buxtehudedermato-Onkologie Studienzentrale
Buxtehude, Germany
- Uniklinikum Dresden Klinik Und Poliklinik Für Dermatologie
Dresden, Germany
- Universitätshautklinik Frankfurt
Frankfurt, Germany
- Medizinische Hochschule Hannover
Hanover, Germany
- Hno-Universitätsklinik Jena
Jena, Germany
- Universitätshautklinik Magdeburg
Magdeburg, Germany
- Universitätsklinikum Regensburg
Regensburg, Germany
- Universitätsklinikum Tübingen
Tübingen, Germany
- Auckland City Hospital
Auckland, New Zealand
- Christchurch Hospital
Christchurch, New Zealand
- Waikato Hospital
Hamilton, New Zealand
- University of Alabama
Birmingham, Alabama, United States
- University of Alabama School of Medicine
Birmingham, Alabama, United States
- University of Arizona Cancer Center
Tucson, Arizona, United States
- University of California, Los Angeles
Los Angeles, California, United States
- Stanford Hospitals and Clinics
Palo Alto, California, United States
- University of California, San Diego
San Diego, California, United States
- University of California San Francisco
San Francisco, California, United States
- University of Colorado
Aurora, Colorado, United States
- Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, United States
- Georgia Cancer Center - Northside Hospital Central Research Department
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- University of Iowa Healthcare
Iowa City, Iowa, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- University of Minnesota Masonic Cancer Center
Minneapolis, Minnesota, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Atlantic Health
Morristown, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Levine Cancer Institute
Charlotte, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- the Christ Hospital
Cincinnati, Ohio, United States
- University Hospitals Cleveland Medical Center - Seidman Cancer Center
Cleveland, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2015
- Primary completion
- 30 Apr 2020
- Completion
- 30 Apr 2020
- Last update posted
- 3 Aug 2021
- Registered enrollment
- 241
- Registry id
- NCT02521870
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.